日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Efficacy and safety of ME3183, an oral phosphodiesterase 4 inhibitor, in patients with plaque psoriasis

口服磷酸二酯酶4抑制剂ME3183治疗斑块状银屑病患者的疗效和安全性

Papp, Kim A; Armstrong, April W; Koresawa, Tomokazu; Otake, Kazunari; Hirata, Masayuki; Kano, Akiko

Poster Session I - A110 TRENDS IN SPENDING ON ADVANCED IBD THERAPIES PRESCRIBED BY GASTROENTEROLOGISTS IN MEDICARE

海报展示环节 I - A110 医疗保险中胃肠病学家开具的先进炎症性肠病 (IBD) 疗法支出趋势

Blauvelt, Andrew; Gooderham, Melinda; Griffiths, Christopher E M; Armstrong, April W; Zhu, Baojin; Burge, Russel; Gallo, Gaia; Guo, Jiaying; Garrelts, Alyssa; Lebwohl, Mark; Raber, M; Lu, C; Ma, C; Nasser, Y; Congly, S

Systemic Corticosteroid Exposure in Patients with Atopic Dermatitis: A US Population-Based Study

美国人群研究:特应性皮炎患者全身性糖皮质激素暴露情况

Bunick, Christopher G; Vleugels, Ruth Ann; Lebwohl, Mark; Armstrong, April W; Grada, Ayman; Yue, Emma Xiaomeng; Saranadasa, Madhi; Wegrzyn, Lani; D'Andrea, Elvira

Deucravacitinib in Plaque Psoriasis After Inadequate Response to Apremilast: Phase 3 POETYK Analysis

Deucravacitinib治疗对Apremilast疗效不佳的斑块状银屑病:POETYK III期分析

Armstrong, April W; Warren, Richard B; Sofen, Howard; Spelman, Lynda; Linaberry, Misti; Becker, Brandon; Jou, Ying-Ming; Daamen, Carolin; Kimball, Alexa B

Role of real-world evidence from patient registries for psoriasis in decision-making: a systematic review

银屑病患者登记库中真实世界证据在决策中的作用:一项系统评价

Passero, Lauren; Simon, Teresa A; Zhong, Yichen; Zhuo, Joe; Varga, Stefan; Armstrong, April W

Association between out-of-pocket costs and treatment patterns in psoriasis and psoriatic arthritis: A claims-based cohort study

银屑病和银屑病关节炎患者自付费用与治疗模式之间的关联:一项基于医疗保险索赔数据的队列研究

Roberts, Alyssa M; Jeong, Charlotte; Chou, Peichi; Ma, Elaine J; Katz, Abigail; Yan, Matthew J; Johnsen, Nicole; Nong, Yvonne; Armstrong, April W

An atypical case of pemphigus herpetiformis with erythroderma

一例伴有红皮病的非典型疱疹样天疱疮

Jeong, Charlotte; Chou, Peichi P; Dong, Elaine; Shen, Amy; McKenzie, Shanice; Lane, Fiona; Smart, Chandra; Kang, Yuna; Kasperkiewicz, Michael; Armstrong, April W

Is Cumulative Life Course Impairment Considered in Psoriasis Management? A Multinational Survey of People with Psoriasis and Healthcare Professionals

银屑病管理中是否考虑了累积生命历程损害?一项针对银屑病患者和医疗保健专业人员的多国调查

Matthews, Raymond; Armstrong, April W; Augustin, Matthias; Baker, Christopher; Carrascosa, José Manuel; Kirby, Brian; Langley, Richard; McBride, Sandy; Reich, Adam; Romiti, Ricardo; Sampogna, Francesca; Warren, Richard B

Cathepsin C (dipeptidyl peptidase 1) inhibition in adults with bronchiectasis: AIRLEAF, a phase II randomised, double-blind, placebo-controlled, dose-finding study

组织蛋白酶C(二肽基肽酶1)抑制剂治疗成人支气管扩张症:AIRLEAF,一项II期随机、双盲、安慰剂对照、剂量探索研究

Chalmers, James D; Shteinberg, Michal; Mall, Marcus A; O'Donnell, Anne E; Watz, Henrik; Gupta, Abhya; Frahm, Edith; Eleftheraki, Anastasia; Rauch, Johanna; Chotirmall, Sanjay H; Armstrong, April W; Eickholz, Peter; Hasegawa, Naoki; Sauter, Wiebke; McShane, Pamela J

Safety and Efficacy of Deucravacitinib in Moderate to Severe Plaque Psoriasis for Up to 3 Years: An Open-Label Extension of Randomized Clinical Trials

Deucravacitinib治疗中重度斑块状银屑病长达3年的安全性和有效性:一项随机临床试验的开放标签扩展研究

Armstrong, April W; Lebwohl, Mark; Warren, Richard B; Sofen, Howard; Imafuku, Shinichi; Ohtsuki, Mamitaro; Spelman, Lynda; Passeron, Thierry; Papp, Kim A; Kisa, Renata M; Vaile, John; Berger, Victoria; Vritzali, Eleni; Hoyt, Kim; Colombo, Matthew J; Scotto, Julie; Banerjee, Subhashis; Strober, Bruce; Thaçi, Diamant; Blauvelt, Andrew